Works matching IS 25094254 AND DT 2024 AND VI 8 AND IP 5
Results: 14
Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 773, doi. 10.1007/s41669-024-00509-3
- By:
- Publication type:
- Article
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 727, doi. 10.1007/s41669-024-00508-4
- By:
- Publication type:
- Article
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 715, doi. 10.1007/s41669-024-00504-8
- By:
- Publication type:
- Article
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 651, doi. 10.1007/s41669-024-00503-9
- By:
- Publication type:
- Article
Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 665, doi. 10.1007/s41669-024-00501-x
- By:
- Publication type:
- Article
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 689, doi. 10.1007/s41669-024-00500-y
- By:
- Publication type:
- Article
Correction: NICE's Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A Cost Evaluation of COVID-19 Remote Home Monitoring Services in England.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 739, doi. 10.1007/s41669-024-00498-3
- By:
- Publication type:
- Article
Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 701, doi. 10.1007/s41669-024-00497-4
- By:
- Publication type:
- Article
Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature Review.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 765, doi. 10.1007/s41669-024-00496-5
- By:
- Publication type:
- Article
ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 755, doi. 10.1007/s41669-024-00493-8
- By:
- Publication type:
- Article
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 679, doi. 10.1007/s41669-024-00491-w
- By:
- Publication type:
- Article
NICE's Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances.
- Published in:
- 2024
- By:
- Publication type:
- Editorial